Fundraising Fox

Nexgel

NASDAQ: NXGL

Langhorne, US · Delaware corporation

NEXGEL manufactures hydrogel patches using its platform technology, produced with or without active ingredients for applications including OTC medications, wound care, cosmetics, and other commercial products. It operates an FDA-registered, ISO-certified cGMP manufacturing facility with R&D and converting operations for custom hydrogel development.

Founders & leadership

AL
Adam LevyChief Executive Officer and Chief Financial Officer

Board

DS
David StefanskyBoard director
NS
Nachum SteinBoard director
JZ
Jerome ZeldisBoard director

Reported raises · per SEC filings

Form D private placements

$4.2M disclosed across 5 rounds · 2019–2021

$1.6MraisedSep 2021 · 20 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Nachum SteinDirector
  • Adam DrapczukExecutive Officer
  • David StefanskyDirector
  • Adam LevyExecutive Officer, Director
  • Yaakov SpinradDirector
  • Jerome ZeldisDirector
  • Miranda J ToledanoDirector
Offering amount
$2.5M
Amount sold
$1.6M
Sales commissions
$115.6K
Placement agents
Alere Financial Partners, A Division of Cova Capital Partners, LLC
First sale
Sep 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$1.5MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jerome ZeldisDirector
  • Nachum SteinDirector
  • David StefanskyDirector
  • Adam LevyExecutive Officer
  • Steven Mark GlassmanDirector
Offering amount
$1.5M
Amount sold
$1.5M
Sales commissions
$120K
Placement agents
Alere Financial Partners, A Division of Cova Capital Partners, LLC
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$515KraisedMar 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jerome ZeldisDirector
  • Nachum SteinDirector
  • David StefanskyDirector
  • Adam LevyExecutive Officer
  • Steven Mark GlassmanDirector
Offering amount
$515K
Amount sold
$515K
Minimum investment
$25K
Sales commissions
$41.2K
Placement agents
Alere Financial Partners, A Division of Cova Capital Partners, LLC
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$395.1KraisedAug 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Adam LevyExecutive Officer
  • Nachum SteinDirector
  • Jerome ZeldisDirector
  • David StefanskyDirector
Offering amount
$500K
Amount sold
$395.1K
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$175KraisedSep 2019 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David StefanskyDirector
  • Nachum SteinDirector
  • Adam R. LevyExecutive Officer
  • Joe WilliamsExecutive Officer
Offering amount
$750K
Amount sold
$175K
Sales commissions
$45K
Placement agents
Alere Financial Partners, A Division of Cova Capital Partners, LLC
First sale
Sep 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Nexgel for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Nexgel do?
NEXGEL manufactures hydrogel patches using its platform technology, produced with or without active ingredients for applications including OTC medications, wound care, cosmetics, and other commercial products. It operates an FDA-registered, ISO-certified cGMP manufacturing facility with R&D and converting operations for custom hydrogel development.
How much funding has Nexgel raised?
Nexgel has disclosed $4.2M raised across 5 rounds.
Where is Nexgel headquartered?
Nexgel is headquartered in Langhorne, US.